METLIFE INC (MET) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does METLIFE INC Do?
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. METLIFE INC (MET) is classified as a large-cap stock in the Financials sector, specifically within the Insurance industry. The company is led by CEO Michel A. Khalaf and employs approximately 45,000 people, headquartered in New York, New York. With a market capitalization of $46.4B, MET is one of the prominent companies in the Financials sector.
METLIFE INC (MET) Stock Rating — Hold (April 2026)
As of April 2026, METLIFE INC receives a Hold rating with a composite score of 49.7/100 and 3 out of 5 stars from the Blank Capital Research quantitative model.MET ranks #1,403 out of 4,446 stocks in our coverage universe. Within the Financials sector, METLIFE INC ranks #421 of 891 stocks, placing it in the upper half of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
MET Stock Price and 52-Week Range
METLIFE INC (MET) currently trades at $73.88. The stock lost $0.77 (1.0%) in the most recent trading session. The 52-week high for MET is $85.00, which means the stock is currently trading -13.1% from its annual peak. The 52-week low is $65.21, putting the stock 13.3% above its annual trough. Recent trading volume was 2.3M shares, reflecting moderate market activity.
Is MET Overvalued or Undervalued? — Valuation Analysis
METLIFE INC (MET) carries a value factor score of 75/100 in the Blank Capital model, suggesting the stock trades at a meaningful discount to its fundamental earning power. The trailing price-to-earnings ratio is 11.82x, compared to the Financials sector average of 14.88x — a discount of 21%. The price-to-book ratio stands at 1.62x, versus the sector average of 1.22x. The price-to-sales ratio is 0.65x, compared to 0.90x for the average Financials stock. On an enterprise value basis, MET trades at 7.20x EV/EBITDA, versus 3.26x for the sector.
Based on these multiples, METLIFE INC appears attractively valued relative to both its sector peers and the broader market. Value-oriented investors may find the current entry point compelling, particularly if the company's fundamental quality metrics also score well.
METLIFE INC Profitability — ROE, Margins, and Quality Score
METLIFE INC (MET) earns a quality factor score of 57/100, indicating solid business quality with consistent operational execution. The return on equity (ROE) is 13.7%, compared to the Financials sector average of 8.5%, which is within a healthy range. Return on assets (ROA) comes in at 0.5% versus the sector average of 1.2%.
On a margin basis, METLIFE INC reports gross margins of 0.0%. The operating margin is 8.4% (sector: 21.8%). Net profit margin stands at 5.5%, versus 17.7% for the average Financials stock. Revenue growth is running at -2.6% on a trailing basis, compared to 9.4% for the sector. The overall profitability profile is adequate, though there may be room for margin expansion.
MET Debt, Balance Sheet, and Financial Health
METLIFE INC has a debt-to-equity ratio of 2497.0%, compared to the Financials sector average of 121.0%. This elevated leverage warrants close monitoring, as it increases the company's sensitivity to rising interest rates and economic downturns. The current ratio is 1.04x, suggesting adequate working capital coverage. Total debt on the balance sheet is $37.37B. Cash and equivalents stand at $20.23B.
MET has a beta of 1.13, meaning it is roughly in line with the broader market in terms of price volatility. The stability factor score for METLIFE INC is 75/100, indicating low-volatility characteristics and consistent price behavior that appeals to risk-averse investors.
METLIFE INC Revenue and Earnings History — Quarterly Trend
In TTM 2026, METLIFE INC reported revenue of $71.18B and earnings per share (EPS) of $4.74. Net income for the quarter was $3.93B. Gross margin was 0.0%. Operating income came in at $22.37B.
In FY 2025, METLIFE INC reported revenue of $77.08B and earnings per share (EPS) of $4.74. Net income for the quarter was $3.40B. Revenue grew 8.6% year-over-year compared to FY 2024. Operating income came in at $6.14B.
In Q3 2025, METLIFE INC reported revenue of $17.36B and earnings per share (EPS) of $1.23. Net income for the quarter was $902M. Revenue grew -3.1% year-over-year compared to Q3 2024. Operating income came in at $1.65B.
In Q2 2025, METLIFE INC reported revenue of $17.34B and earnings per share (EPS) of $1.04. Net income for the quarter was $735M. Revenue grew -2.7% year-over-year compared to Q2 2024. Operating income came in at $1.39B.
Over the past 8 quarters, METLIFE INC has demonstrated a growth trajectory, with revenue expanding from $17.82B to $71.18B. Investors analyzing MET stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
MET Dividend Yield and Income Analysis
METLIFE INC (MET) currently pays a dividend yield of 2.7%. At this yield, a $10,000 investment in MET stock would generate approximately $$272.00 in annual dividend income. This compares to the Financials sector average dividend yield of 2.5%, meaning MET offers above-average income for its sector. The net margin of 5.5% provides reasonable coverage for the dividend, though investors should monitor payout sustainability.
MET Momentum and Technical Analysis Profile
METLIFE INC (MET) has a momentum factor score of 33/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 34/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 22/100 signals elevated short interest, which can indicate bearish sentiment among institutional investors.
MET vs Competitors — Financials Sector Ranking and Peer Comparison
Within the Financials sector, METLIFE INC (MET) ranks #421 out of 891 stocks based on the Blank Capital composite score. This places MET in the upper half of all Financials stocks in our coverage universe. Key competitors and sector peers include WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) with a score of 62.9/100, OPPENHEIMER HOLDINGS INC (OPY) with a score of 62.6/100, Enact Holdings, Inc. (ACT) with a score of 61.6/100, International General Insurance Holdings Ltd. (IGIC) with a score of 61.3/100, and PARKE BANCORP, INC. (PKBK) with a score of 60.4/100.
Comparing MET against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full MET vs S&P 500 (SPY) comparison to assess how METLIFE INC stacks up against the broader market across all factor dimensions.
MET Next Earnings Date
No upcoming earnings date has been announced for METLIFE INC (MET) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy MET? — Investment Thesis Summary
METLIFE INC presents a balanced picture with arguments on both sides. The value score of 75/100 suggests attractive pricing relative to fundamentals. Momentum is weak at 33/100, a headwind for near-term performance. Low volatility (stability score 75/100) reduces downside risk.
In summary, METLIFE INC (MET) earns a Hold rating with a composite score of 49.7/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on MET stock.
Related Resources for MET Investors
Explore more research and tools: MET vs S&P 500 comparison, top Financials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare MET head-to-head with peers: MET vs WTM, MET vs OPY, MET vs ACT.